Insider Transactions in Q1 2026 at Cidara Therapeutics, Inc. (CDTX)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2026
|
Ra Capital Management, L.P. |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,652,309
-100.0%
|
$1,028,160,289
$221.5 P/Share
|
|
Jan 07
2026
|
Ra Capital Management, L.P. |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,286,786
+21.67%
|
-
|
|
Jan 07
2026
|
Frank Karbe Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,651
-57.43%
|
$11,193,871
$221.5 P/Share
|
|
Jan 07
2026
|
Jeffrey Stein President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
69,877
-100.0%
|
$15,442,817
$221.5 P/Share
|
|
Jan 07
2026
|
Jeffrey Stein President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,763
-100.0%
|
$1,273,623
$221.5 P/Share
|
|
Jan 07
2026
|
Daniel D Burgess Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
150
-100.0%
|
$33,150
$221.5 P/Share
|
|
Jan 07
2026
|
Chrysa Mineo Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,320
-100.0%
|
$733,720
$221.5 P/Share
|
|
Jan 07
2026
|
Bonnie L Bassler Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15
-100.0%
|
$3,315
$221.5 P/Share
|
|
Jan 07
2026
|
Nicole Negar Davarpanah Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,886
-80.05%
|
$4,615,806
$221.5 P/Share
|
|
Jan 07
2026
|
Shane Ward COO & CLO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,083
-100.0%
|
$5,543,343
$221.5 P/Share
|